The largest database of trusted experimental protocols

5 protocols using fitc cd45.1 a20

1

Bone Marrow Cell Transplantation Chimerism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to injection, 1 × 106 donor bone marrow cells from CD82KO (CD45.2) or WT (CD45.2) were treated with 5 μM EHop-016 (Selleckchem) or 50 μM NSC23766 (Cayman Chemical) in SFEM for 1 h at 37°C. Treated cells were then retroorbitally injected into BoyJ recipient mice (CD45.1). Recipient mice underwent total body irradiation 24 h prior to injection, which was administered as a single dose of 10 Gy. Mice were killed 16 h postinjection to assess chimerism of the bone marrow and peripheral blood. Blood and bone marrow samples were treated with Fc block prior to labeling with directly conjugated fluorescent antibodies FITC CD45.1 (A20; BD Pharmingen) and APC CD45.2 (104; BD Pharmingen) to assess chimerism. Samples were analyzed on the LSR Fortessa (BD Bioscience).
+ Open protocol
+ Expand
2

Competitive Bone Marrow Repopulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For noncompetitive repopulation assay, 1 × 106 donor Lin bone marrow cells from CD82KO or WT (CD45.2) were retroorbitally injected into recipient BoyJ mice (CD45.1). For a competitive repopulation assay, 1 × 106 donor Lin bone marrow cells from CD82KO (CD45.2) were mixed at a ratio of 1:1 with Lin BoyJ cells (CD45.1) and were retroorbitally injected into recipient chimeric mice (CD45.1/CD45.2). Recipient mice underwent total body irradiation, which was administered as a single dose of 10 Gy. Each month, blood was taken from tail snips to assess chimerism and immune cell differentiation. Cells were treated with Fc block prior to staining with the following directly conjugated fluorescent antibodies: FITC CD45.1 (A20; BD Pharmingen), APC CD45.2 (104; BD Pharmingen), PerCP-Cy5.5 CD3 (145-2C11; BD Pharmingen), BV421 B220 (RA3-6B2; Biolegend), Pe-Cy7 Ly6G (IA8; BD Pharmingen), and Pe-Cy7 CD11b (MI/70; BD Pharmingen). Labeled blood samples were analyzed using the LSR Fortessa (BD Bioscience).
+ Open protocol
+ Expand
3

Competitive Homing of CD82-Deficient Bone Marrow Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For a noncompetitive homing experiment, 1 × 106 donor bone marrow cells from CD82KO or WT (CD45.2) were retroorbitally injected into recipient chimeric mice (CD45.1/CD45.2). For a competitive homing experiment, donor bone marrow cells from CD82KO were mixed at a ratio of 1:1 with BoyJ competition bone marrow cells and injected into chimeric recipient mice. Competitive homing experiments were also performed using isolated HSPCs from the bone marrow as described above. Recipient mice underwent total body irradiation, which was administered as a single dose of 10 Gy. Mice were killed 16 h postinjection to assess chimerism of the bone marrow and peripheral blood. Blood and bone marrow samples were treated with Fc block prior to labeling with directly conjugated fluorescent antibodies, FITC CD45.1 (A20; BD Pharmingen), and APC CD45.2 (104; BD Pharmingen) to assess chimerism. Samples were analyzed on the LSR Fortessa (BD Bioscience).
+ Open protocol
+ Expand
4

Immune Cell Profiling of Tumor and Lymph Nodes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors and tumor-draining inguinal lymph nodes (TDLNs) were excised from animals sacrificed 24 hours after i.t. CDN injection in media containing 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL). These tissues were manually dissociated with scissors and syringe plungers, filtered with 70-μm mesh, manually dissociated over a 70-μm mesh filter a second time if needed, then resuspended for antibody staining. Flow cytometry antibodies included: from BioLegend— CD11b-AF700 (M1/70), CD11c-FITC (N418), CD86-PE (GL-1), CD19-PerCP-Cy5.5 (6D5), Ly6C-BV605 (HK1.4), CD45.2-APC (104), IA/IE-PerCP-Cy5.5 (M5/114.15.2), Ly6G-BV421 (1A8), CD16/32-BV510 (93), F4/80-PE-Cy7 (BM8), Ly6c–PerCP-Cy5.5 (HK1.4), and CD4-BV605 (GK1.5) from EBioscience—NK1.1-PE (PK136) and CD8–PE-Cy7 (53-6.7); CD4-Pacific Orange (RM4-5) from Life Technologies; and CD45.1-FITC (A20) from BD Pharmingen. Samples were analyzed using an LSR II cytometer with FACSDiva software (BD Biosciences), and data were quantified using FlowJo software (Tree Star, Inc.) or Cytobank (Cytobank, Inc.).
+ Open protocol
+ Expand
5

Multicolor Flow Cytometry Protocol for Murine Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PB was collected from the retro-orbital plexus in heparinized capillary tubes (Fisherbrand, Pittsburgh, PA) and lysed in red blood cell lysis buffer (Sigma-Aldrich, St. Louis, MO). Cells were stained with the following antibodies: CD45.1-APC (A20) (Biolegend, San Diego, CA) or CD45.1-FITC (A20) (BD Biosciences, San Diego, CA), B220-PECy7 and CD8-PECy7 (53–6.7) (Tonbo Biosciences, San Diego, CA), CD45.2-V500 (104), B220- PerCPCy5.5 (RA3-6B2), Gr1-PerCPCy5.5 (RB6-8C5), Cd11b-PerCPCy5.5 (M1/70) and CD4-PECy7 (RM4-5) (BD Biosciences, San Diego, CA). All antibodies were used at 1:200 dilution. 4’,6-diamidino-2-phenylindole (DAPI) staining was used to gate live events. Analysis was performed on a LSR Fortessa and a BD FACSAria III SORP (Special Order Research Product, which contains the following LASERs: 405 nm, 445 nm, 488 nm, 562 nm, and 640 nm) (both BD Biosciences, San Diego, CA) and the data analyzed with FlowJo version 9.4.11 (Tree Star, Ashland, OR). To discern the four Confetti colors: the filter arrangements for each LASER were: CFP, 445 nm LASER—470/24 band-pass filter (BP); GFP, 488 nm LASER—515/20 BP and 505 long-pass filter (LP); YFP, 488 nm LASER—545/10 BP and 525 LP; RFP, 562 nm LASER—610/20 BP and 600 LP48 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!